Immunocore Holdings Ltd (IMCR) stock news · rev $400.0M
Immunocore Holdings Ltd (IMCR) is a biotechnology company listed on NASDAQ.
This IMCR news page leads with what Immunocore Holdings Ltd filed — not a scraped headline mill.
No cached 8-K sentence for IMCR yet. We will not pad this page with generic market recap.
Latest reported IMCR revenue for 2025-12-31 was $400.0M. Net income was -$35.5M. Revenue was up 29.0% from 2024-12-31 to 2025-12-31. IMCR currently screens at market cap $1.45B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the IMCR stock page; for the tape open the quote page.
IMCR stock news FAQ
What are IMCR's latest revenue and net income?
Latest cached Immunocore Holdings Ltd (IMCR) revenue for Dec 31, 2025 was $400.0M. Net income was -$35.5M. Statements: https://lician.com/financials/imcr
How did IMCR revenue change from the prior cached period?
Cached Immunocore Holdings Ltd (IMCR) revenue was up 29.0% from $310.2M (Dec 31, 2024) to $400.0M (Dec 31, 2025). Statements: https://lician.com/financials/imcr
What is IMCR's market cap?
Immunocore Holdings Ltd (IMCR) market cap is $1.45B on the latest cached fundamentals snapshot.
What kind of company is IMCR?
Immunocore Holdings Ltd (IMCR) is a biotechnology company listed on NASDAQ.
Where is IMCR stock news listed?
Cached stock news for Immunocore Holdings Ltd (IMCR) is listed at https://lician.com/news/imcr. Filings: https://lician.com/sec/imcr
Not investment advice.